• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC PUERTO RICO OPERATIONS CO. SURESCAN; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC PUERTO RICO OPERATIONS CO. SURESCAN; STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF Back to Search Results
Model Number 97712
Device Problems Overheating of Device (1437); Improper or Incorrect Procedure or Method (2017); Delayed Charge Time (2586); Battery Problem (2885); Charging Problem (2892)
Patient Problems Burn(s) (1757); Edema (1820); Erythema (1840); Pain (1994); Therapeutic Effects, Unexpected (2099); Burning Sensation (2146); Therapeutic Response, Decreased (2271)
Event Date 11/01/2018
Event Type  Injury  
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Information was received from a distributor via a manufacturer representative regarding the patient who was implanted with an implantable neurostimulator (ins) for a diagnosis of lumbar disc herniation.Burns, over discharge, and symptom return were reported.Four months prior to (b)(6) 2018, the implant site of the ins began to warm up during the recharge procedure.When asked if they had noticed any abnormality with the charging system, the patient informed that the equipment did not present with any error message or icon that made them suspect a malfunction, only that the intervals between one charge had decreased from one week to one day, the process of recharging the ins was slower than usual taking about eight hours to complete a charge, and that the feeling of heat that was gradually intensifying.According to telemetry on (b)(6) 2018 with the physician programmer, it was noticed that the coupling between the recharging system and its status was fine, but the battery life was lower than expected for the programmed parameters.In the week of (b)(6) 2018, the patient suffered burns while charging the device.Images of the burns were provided.It was noted that the spinal cord stimulation therapy worked perfectly until this issue began.Tests with the recharger system, and telemetry analysis were done without results.Tests with another recharger system was done, but the issue was not resolved as of (b)(6) 2018.Symptoms included a burning sensation, pain, redness, less than 50% therapy relief, and edema.The location of the issue/symptoms was the device pocket.No medical or surgical intervention was needed to prevent a permanent impairment of function.The event did not lead to or extend patient hospitalization.The burns were a temporary injury as a result of the event, and the patient was alive.It was noted that a replacement ins was required.The telemetry printout was provided.
 
Manufacturer Narrative
If information is provided in the future, a supplemental report will be issued.
 
Event Description
Additional information was received from the manufacturer representative.It was reported that the cause of the burning sensation when recharging was not determined.The replacement of the generator was planned, but had not happened as of (b)(6) 2018 yet because the patient was going through pre-operative examinations and waiting for the insurance company approval.The distributor team was oriented to return the device to the manufacturer when the explant occurs.No further actions/interventions had occurred as they were waiting for the explant of the device.It was noted that this information was confirmed with the physician/account.
 
Manufacturer Narrative
Device evaluation: analysis of the implantable neurostimulator (ins) found the ins battery had reduced capacity due to overdischarge.Additionally, analysis of ins heating during recharging found there was no evidence to suggests the device behaved differently than a known good control device.If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
Analysis results were not available as of the date of this report.A follow-up report will be submitted when analysis is complete.(b)(4).If information is provided in the future, a supplemental report will be issued.
 
Manufacturer Narrative
H2.Correction: upon further review, d6 was known.Medtronic, inc.(medtronic) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information in the time allotted and has provided as much information as is available to the company as of the submission date this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic or its employees caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any "defects" or has "malfunctioned".These words are included in the fda 3500a form and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.Medtronic objects to the use of these words and others like it because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SURESCAN
Type of Device
STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF
Manufacturer (Section D)
MEDTRONIC PUERTO RICO OPERATIONS CO.
road 31, km. 24, hm 4
ceiba norte industrial park
juncos PR 00777
MDR Report Key8108210
MDR Text Key129085169
Report Number3004209178-2018-26335
Device Sequence Number1
Product Code LGW
Combination Product (y/n)N
PMA/PMN Number
P840001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/27/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/14/2017
Device Model Number97712
Device Catalogue Number97712
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/29/2019
Date Manufacturer Received08/20/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-